Tuesday - November 3, 2026
FDA Center for Devices & Radiological Health Issues Warning Letter to Chirp Innovations
October 28, 2026
WASHINGTON, Oct. 28 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Chirp Innovations LLC from its Center for Devices and Radiological Health:

* * *

Recipient: Tate S. Stock, Chief Executive Officer, Chirp Innovations, LLC, 3900 Traverse Mountain Blvd Ste 300, Lehi, UT 84043, United States

(b)(6), (b)(7)(C)

Issuing Office: Center for Devices and Radiological Healt . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products